Diagnosis challengeTo achieve rapid scale

It just requires immediate action,” says Charles Gore, President of World Hepatitis Alliance.75 million new hepatitis C cases every year. A record 3 million people were able to obtain treatment for hepatitis C over the past two years, and 2. It’s eminently achievable. Countries need to improve policies, and programmes to increase awareness and subsequent diagnosis.However, funding remains a major constraint: Control Cables Suppliers most countries lack adequate financial resources to fund key hepatitis services.

“Implementation of elimination strategyThe World Hepatitis Summit 2017 will be attended by over 900 delegates from more than 100 countries, including Ministers of Health, national programme managers, and representatives from organizations of people affected by viral hepatitis.Diagnosis challengeTo achieve rapid scale-up of treatment, countries need urgently to increase uptake of testing and diagnosis for hepatitis B and C. The 2.76 million people were newly treated for hepatitis C , a significant increase on the 1. As of 2015, an estimated 1 in 10 people living with hepatitis B, and 1 in 5 people living with hepatitis C, were aware of their infection.“We have seen a nearly 5-fold increase in the number of countries developing national plans to eliminate life-threatening viral hepatitis over the last 5 years,” says Dr Gottfried Hischall, Director of WHOs Department of HIV and Global Hepatitis Programme.7% in the pre-vaccine era.”“Brazil is honored to host the World Hepatitis Summit 2017 – and welcomes this extraordinary team of experts, researchers, managers and civil society representatives to discuss the global health problem posed by viral hepatitis,” says Dr Adele Schwartz Benzaken, Director of the Brazilian Ministry of Health’s Department of Surveillance, Prevention and Control of STIs, HIV/AIDS and Viral Hepatitis. “The great successes of hepatitis B vaccination programmes in many countries need to be replicated and sustained globally in the context of moving forward to universal health coverage. But these milestones represent only initial steps – access to treatment must be increased globally if the 80% treatment target is to be reached by 2030.8 million additional people starting lifelong treatment for hepatitis B in 2016 was a marked increase from the 1.